Greif Inc-cl B(GEF.B)
$69.47▲1.27%
Market is closed - opens 7 PM, 29 Jul 2024
Insights
- Greif Inc-cl B is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Greif Inc-cl B stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Greif Inc-cl B stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Greif Inc-cl B stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 66.68 | Sell |
Stochastic | 95.43, 89.33 | Neutral |
Ultimate Oscillator | 58.13 | Neutral |
Stochastic Relative Strength Index | 79.36, 77.09 | Neutral |
Moving Average Convergence Divergence | 1.38, 0.89 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 67.27 | Buy |
20 | 64.46 | Buy |
50 | 64.13 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 66.91 | Buy |
20 | 65.6 | Buy |
50 | 64.59 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 67.29 | Neutral |
20 | 63.97 | Buy |
50 | 64.02 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 68.52 | Buy |
20 | 67.25 | Buy |
50 | 65.09 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 68.84 | Buy |
20 | 68.52 | Buy |
50 | 65.72 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 70.23 |
Resistance L2 | 69.37 |
Resistance L1 | 68.51 |
Pivot Point | 67.64 |
Support L1 | 66.78 |
Support L2 | 65.92 |
Support L3 | 65.06 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.